The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.


No early rate and no onsite registration possible.

CDDF Industry partners (*) Free Email at to register
Industry Representatives

(not partners of CDDF)

EUR 6000




Non-commercial participants

(academia/ foundations / charities)

EUR 300
Representatives from regulatory authorities (EMA, FDA, national agencies and HTA bodies) (**) Free
Nurses & Students  (***) Free
Patient Advocates (****) Free

(*) The CDDF Industry Partners are entitled to three free registrations per workshop. Any additional registrations required will be granted at a reduced price of 1,500 Euro each. To register, please email to

(**) The representative from regulatory authorities’ rate applies exclusively for individuals who are employed by regulatory authorities such as EMA, FDA, national agencies and HTA bodies. To register, please provide proof of employment via the registration page.

(***) As for students, confirmation of ‘in training’ status from the Head of Department is required; the fee is only applicable for Master and PhD Students as well as Residents in training. To register, please provide a copy of a student ID via the registration page. Networking dinner &lunch package is optional (100 EUR).

(****) The Patient Advocate’s rate applies exclusively for individuals who are a member of a Patient Advocacy Organisation. To register, provide proof of membership via the registration page.


  • Admission to all conference sessions
  • Coffee breaks & lunch on 8 – 10 February, 2021
  • Networking dinners on 8 & 10 February, 2021
  • Access to presentations & meeting report after the conference

Please note that only written cancellations addressed to will be accepted.

The following rules apply:

  • Before 8 January: 50% refund
  • After 8 January: no refund

Any replacement (i.e. change of delegate name) of a confirmed registration is subject to a 50  EUR charge per participant.


Please read carefully the ‘Data Protection Policy’

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70